Hannover House Submits 2012 Release Slate and Forecasts for Corporate
Finance Opportunities
Company forecasts growth of over 100% for current year, over 2011
results.
Los Angeles, CA, May 30, 2012 (GlobeNewswire via COMTEX) -- Sales
revenues during calendar year 2012 for independent studio Hannover
House (otc markets:HHSE) will reflect the company's ongoing commitment
to the home video market, as well as new activities in presales and
licensing to international buyers, said Eric Parkinson, C.E.O. For
2012, the company has set a revenue goal of 11.7-million, with a
projected pre-tax operating margin of about 2.1-million. Titles
contributing the most towards revenues include the August theatrical
release of "Toys in the Attic," (starring Academy Award winner Forest
Whitaker) and international presales for the fall 2012 production of
"Mother Goose" (starring Academy Award winner Shirley MacLaine).
The revenue projections were released today in compliance with public
company guidelines requiring access to information that might
otherwise be considered preferential and non-public. Parkinson is
meeting with corporate financing parties in Los Angeles this week, and
will be discussing the Hannover House release slate and forecasts.
International pre-sales for "Mother Goose" and three other titles
represented worldwide by Hannover House are projected to be the
largest revenue contributors for the company during 2012. Foreign
presales and licenses are expected to generate about 43% of total
revenues, even after dividing the realization of revenues equally
between contract date and delivery. Home Video sales are expected to
generate about 36% of total 2012 revenues, and theatrical sales are
forecasted at about 18% for the year. Television licenses and book
sales are expected to generate together less than 3% of total
revenues. Not included in these forecasts are sales for merchandising
items supporting the release of "Toys in the Attic," and sales for the
upcoming launch of the VODwiz.com internet streaming portal. Both
items have been excluded from forecasts due to the lack of sales
history at Hannover House. Home video sales for "Toys in the Attic"
are expected to be recognized in January, 2013, rather than during
calendar year 2012, based on the January street date, and not the date
of manufacture and shipment (which is projected for mid-December) .
Revenues for 2013 are expected to grow significantly over 2012, based
on modest projections for "Mother Goose," and conservative forecasts
for 20 additional titles, including film output agreements with Origin
Film Partners and Allegheny Image Factory.
Hannover House has been operating since 1993, and has posted nine
consecutive quarters of profitability since becoming publicly traded
on the OTC Markets. The company's primary offices are in N.W.
Arkansas, but will expand this summer to include an ofice presence in
Los Angeles to facilitate relationships with the production community,
and corporate financing sources.
http://www.marketwatch.com/story/hannover-hou...2012-05-30
Hannover House Submits 2012 Release Slate and Forecasts for
Top 10 Most Recent News Articles
Webull Faces Class Action: Key Details for Investors
What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...
Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance
Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...
Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results
Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...
Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion
Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...
Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026
Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...
Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices
Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...
Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart
A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...
Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West
Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...
Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years
A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...
Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa
Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...
Continue ReadingTop 5 Most Recently Viewed Articles
Exploring the Growth of the Sodium Bisulfite Market by 2034
Understanding the Growth of the Sodium Bisulfite Market The sodium bisulfite market is experiencing significant momentum as it progresses towards a bright future, with expectations of reaching USD 1,180.7 million by 2034, up from USD 750.3 million in 2024. This growth is driven by an increasing awareness of environmental issues and its versatile applications in various...
Continue Reading
Photocure ASA Reports Impressive Q2 Growth and Outlook
Photocure ASA Achieves Record Revenue in Q2 Photocure ASA has shared strong results for the second quarter of the year, showcasing remarkable growth in its Hexvix/Cysview product line. This quarter marked an unprecedented achievement with revenues reaching NOK 135.6 million, reflecting a significant increase compared to NOK 122.4 million from the same period last year....
Continue Reading
Ben & Jerry's Unveils New Flavor Inspired by Noah Kahan
Ben & Jerry's Launches Exclusive Flavor with Noah Kahan Ben & Jerry's, the iconic ice cream brand that loves to explore creative flavors, has just introduced an exciting new flavor called Northern Latte-tude. This one-of-a-kind creation is the result of a collaboration with musician Noah Kahan, with the goal of not only delighting fans but also supporting an important...
Continue Reading
Cisco Analyst Coverage Initiation Highlights: Stocks to Watch
Latest Analyst Ratings on Notable Stocks In a dynamic market environment, top analysts analyze and provide insights on various companies. Recently, several key analysts have shared significant ratings and price targets for notable stocks, including Cisco Systems, Inc. (NASDAQ: CSCO) and Shopify Inc. (NASDAQ: SHOP). Let's delve into what they have to say. Shopify Inc....
Continue Reading
Nike's Leadership Shakeup: A Bright Future Ahead for the Brand
Nike's Steady Outlook Amid Leadership Changes BMO Capital Markets has recently reaffirmed its Outperform rating for Nike Inc. (NYSE:NKE), setting a price target at $92.00 per share. This positive outlook follows the recent appointment of Elliott Hill as President and CEO, a change many investors have eagerly awaited. Hill's return is seen as a hopeful sign for the...
Continue Reading